Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck’s Ambitious Plans For Follow-On Biologics

Dec 15 2008

• By The Pink Sheet

Related Content

Pharma's New Follow-On Strategy

Feb 01 2008

Big Pharma's Leap into Biologics: Bridging both Scientific and Cultural Gaps

Oct 01 2007

Merck Announces Major FOB Initiative With Its New Business Unit

Dec 09 2008

G-CSF Biosimilars Approved By EU Could Impact Amgen Sales

Sep 24 2008

Biosimilar Competition Debate: Must Products Be Interchangable To Generate Savings?

Nov 25 2008

Big Pharma May Be Big Player in Follow-On Biologics Market

May 01 2008

Teva Bulks Up Biopharma With $400 Million CoGenesys Acquisition

Jan 28 2008

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window